Magnus Confirms 2026 SAINT Payment Stability In CMS OPPS Rule
24 Nov 2025 //
BUSINESSWIRE
Nexstim Provides Further Details on Technology License Agreement with Magnus
12 Jun 2024 //
GLOBENEWSWIRE
Magnus Medical Shares New Study Results With SAINT for Severe Depression
15 May 2023 //
BUSINESSWIRE
Magnus Nylén proposed as new member of the SelectImmune Pharma board
11 Nov 2022 //
CISION
FDA canonizes Saint neurostim system for severe depression
06 Sep 2022 //
FIERCEBIOTECH
Magnus Receives FDA Clearance for the SAINT Neuromodulation System
06 Sep 2022 //
BUSINESSWIRE

Market Place
Sourcing Support